RxDoctor Payments Data

John Beigel

Infectious Disease · Bethesda, MDNPI 1396705372

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $250 of the $250 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Sanofi Pasteur Inc.. That places this record below the midpoint for infectious disease clinicians in MD, where the typical reported total is $209.

$250in general payments, 2019–2025

Across 1 payment — averaging $250.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi Pasteur Inc.$250
$15,040,173in research payments, 2019–2025

Across 2 payments — averaging $7,520,086 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$15M

What the payments were for

  • Speaking & faculty fees$250100%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Sanofi Pasteur Inc.1$250

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$250 in reported general payments places this provider in the 50th percentile of 289 infectious disease providers in Maryland.

See all infectious disease providers in Maryland

Other infectious disease in Bethesda

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →